Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
A Placebo-Controlled Study of a Combination of Metyrapone and Oxazepam in Cocaine Addiction
This study has been completed.
Study NCT00567814 Information provided by Embera NeuroTherapeutics, Inc.
First Received: December 3, 2007 Last Updated: December 30, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cocaine Dependence
Cocaine Addiction
Additional conditions recognized in this trial
Behavior, Addictive
Cocaine-Related Disorders
More general conditions related to this trial
Compulsive Behavior
Disorders of Environmental Origin
Impulsive Behavior
Mental Disorders
Substance-Related Disorders
Interventions listed in this trial
Metyrapone
Oxazepam
Placebo
Additional drug interventions recognized in this trial
Cocaine
More general drug interventions related to this trial
Anesthetics
Anesthetics, Local
Anti-Anxiety Agents
Antimetabolites
Cardiovascular Agents
Central Nervous System Agents
Central Nervous System Depressants
Dopamine Agents
Dopamine Uptake Inhibitors
Enzyme Inhibitors
GABA Agents
GABA Modulators
Hypnotics and Sedatives
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Sensory System Agents
Therapeutic Uses
Tranquilizing Agents
Vasoconstrictor Agents
Sponsors listed in this trial
Embera NeuroTherapeutics, Inc.
Back to top of Main Content
